✦ LIBER ✦

Critical analysis of prostate-specific antigen doubling time calculation methodology

✍ Scribed by Robert S. Svatek; Michael Shulman; Pankaj K. Choudhary; Elie Benaim

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 123 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Observations of prostate specific antige

Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma

✍ Shin Egawa; Kazumasa Matsumoto; Kazuho Suyama; Masatsugu Iwamura; Sadahito Kuwao 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## BACKGROUND. To understand better the natural history and biology of prostate carcinoma occurring in Japanese patients, the authors attempted to define changes with time in prostate specific antigen (PSA) measurements in 48 men with clinically resectable T1-T3 nonmetastatic disease. ## METHODS.

Linear regressive analysis using prostat

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

✍ Anthony V. D'amico; Gerald E. Hanks 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Background. This study was undertaken to calculate the prostate-specific antigen doubling time (PSA-DT) of prostate cancers recurrent after external beam radiation therapy and to investigate if a correlation exists between the PSA-DT and the clinical behavior of prostate cancer as a possible reflect

A Phase II study of oral idarubicin as a

A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time

✍ Hans-Peter Schmid; Rudolf Maibach; Juerg Bernhard; Franz Hering; Silvia Hanselma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Background: Treatment of hormone-refractory prostate carcinoma with chemotherapy is purely palliative, and reported response rates have been low. at the time this study was conducted, there was an urgent need for a trial using potentially efficacious drugs, with quality of life (ql), and serial

Presalvage prostate-specific antigen (PS

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

✍ Philippe E. Spiess; Andrew K. Lee; Dan Leibovici; Xuemei Wang; Kim-Anh Do; Louis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Observations on the doubling time of pro

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

✍ Hans-Peter Schmid; John E. McNeal; Thomas A. Stamey 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB